Senior Mobile App Engineer (React Native)
Beacon Biosignals9 hours ago
Base Salary
$150k - $190k/yr
Responsibilities
- Lead development of React Native mobile applications across iOS and Android.
- Design and implement UX workflows for clinical trial participants and at-home diagnostic patients.
- Own application user experience, performance, reliability, and observability using feedback from real users.
- Integrate capabilities from native iOS and Android BLE device SDKs.
- Partner with Devices, Platform, and Product Design teams to build integrated mobile capabilities.
- Shape the roadmap and technical direction of the mobile platform.
- Build EEG signal-quality validation, patient onboarding, compliance-tracking, performance, release-reliability, and crash-visibility features.
Requirements
- 8+ years of mobile development experience, including substantial experience shipping and maintaining production React Native apps on both iOS and Android.
- Strong TypeScript skills and familiarity with React Native, Expo, and GitHub.
- Experience with app state management, offline-first data handling, and app store release processes.
- Strong product mindset with attention to UX, edge cases, and performance.
- Strong communication skills and comfort working in a collaborative asynchronous environment.
- Experience integrating BLE peripheral devices, sensor integration, or health-data streams is preferred.
- Experience writing native Swift or Kotlin code or building native React Native modules is preferred.
- Experience with medical devices, EEG, wearables, clinical trials, patients, regulated environments, or open-source mobile projects is preferred.
Benefits
- Remote work with asynchronous work practices; candidates may be based in the US Eastern time zone.
- In-person office hubs are available in Boston and New York.
- Total compensation includes equity, PTO, and other benefits.
Tech Stack
Categories
Mobile
About Beacon Biosignals
Beacon Biosignals builds an AI platform and FDA-cleared at-home EEG wearables used by biopharma and clinicians to develop and deliver treatments for neurological, psychiatric, and sleep disorders. It sells clinical development services and software for brain-signal analysis to life sciences partners, and operates a diagnostics business providing reimbursable EEG and cardiopulmonary assessments. Founded in 2019 and headquartered in Boston, the company is privately held.